Venous in Medical Technology
Navigation Links
Venous in Medical Technology
... ---HP802-247---intended for the treatment of venous leg ulcers. HP802-247 is a topical spray ... caused by impaired microcirculation secondary to venous hypertension, venous leg ulcers are increasingly common, are costly, ...
... devices for the minimally invasive treatment of venous reflux disease , announced today that the ... superior" to endovenous laser (EVL) for treating venous reflux, the underlying cause of symptomatic ... the great saphenous vein, the most common site of venous reflux in the leg. The RECOVERY trial was a ...
... trial investigating the efficacy of HP802-247 in venous leg ulcers. HP802-247 is a topical spray ... to placebo plus standard care, in healing venous leg ulcers over a 12-week treatment period. ... involving subjects 18 years of age and older with venous leg ulcers of at least 6 week's, but not more ...
... the focus of a case series on eleven non-healing venous leg ulcers. These wounds had previously failed ... Leptospermum Honey (MEDIHONEY) in Recalcitrant venous Leg Wounds: A Preliminary Case Series" was ... use of MEDIHONEY - particularly in non-healing venous leg ulcers - continues to grow. This case series ...
... adequate blood flow, are known collectively as venous thromboembolism. "Venous thromboembolism ... was the combined occurrence of clinically overt venous or arterial thromboembolic events (i.e., ... the lower and upper limbs, visceral and cerebral venous thrombosis, pulmonary embolism, acute myocardial ...
... collagen product, CellerateRx(R), on diabetic venous ulcers. "According to data released by the ... President of Wound Care Innovations. venous stasis ulcers of the lower extremity is a common ... healthcare system. It has been estimated that venous ulcers cause the loss of approximately 2 million ...
... and controlled clinical trial, looked at venous leg ulcers that had been proven to be non-healing ... paper "Bacteriological Changes in Sloughy venous Leg Ulcers Treated with Manuka Honey or Hydrogel: ... in Ireland. They concluded that for sloughy venous ulcers, "the efficacy of honey in eliminating ...
... better outcomes for AF, venous thromboembolism patients INDIANAPOLIS, March 19 ... medication with chronic atrial fibrillation and venous thromboembolism. "The decision to expand ... Patients prefer fingerstick testing over painful venous draws, according to a 2002 study measuring the ...
... The current healthcare and economic burden of venous thromboembolism (VTE) in U.S. hospitals is ... to improve quality and reduce costs. About venous Thromboembolism (VTE) venous thromboembolism is a general term used to ...
... devices for the minimally invasive treatment of venous reflux disease, announced that interim results ... clearly emerging as the preferred treatment for venous reflux, in part because of reduced patient ... is the best choice for the treatment of venous reflux disease for the millions of varicose vein ...
... placebo one to three minutes prior to undergoing venous access procedures (IV insertions or blood draws). ... age. Its onset of action is one to three minutes. venous access procedures are among the most common ... pre- surgery procedures. "Pain associated with venous access procedures is a common and ...
... system to reduce pain associated with peripheral venous access procedures in adults. Zingo, a ... 16, 2007 to reduce the pain associated with venous access procedures, such as IV insertions or ... indication for children in the coming weeks." venous access procedures, such as IV insertions and ...
... 4568) as a potential treatment for the prevention of both arterial and venous thromboembolism; a Phase III trial is underway among patients with AF. ... as a potential new treatment for the prevention of both arterial and venous thromboembolism. Notably, Daiichi Sankyo has more than 25 years ...
... versus combined placebo and standard care in patients with chronic venous ulcers. The results provided proof-of concept and dose-ranging ... wound healing following laser ablation, burn wounds, surgical wounds, venous ulcers, and diabetic ulcers. About Glycotex, Inc. Glycotex, ...
... therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients ... suggesting that oral, not transdermal estrogen may increase the risk of venous thromboembolism in postmenopausal women." Transdermal estrogen ...
... Perisurgery: PROCRIT (Epoetin alfa) increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. Consider deep venous thrombosis prophylaxis. Contraindications PROCRIT ...
... -- The most common adverse events were related to central venous access, such as catheterization and catheter removal, central line ... or minimally treated patients, infusion site reactions, and central venous access device (CVAD) line-associated infections. Kogenate FS is ...
... however, because of the risks associated with chronic indwelling central venous catheters, including serious blood stream infections, continuous ... infusions of Remodulin are delivered using an indwelling central venous catheter. This route is associated with the risk of blood stream ...
... radiology departments. Abstract 4: "An Endovascular Approach to Deep venous Thrombosis Utilizing Isolated Thrombolysis and Adjunctive Measures," can ... subacute on chronic and 90.9 percent with chronic onset of symptoms, with venous patency achieved in all cases. No adverse events were reported in the ...
... and for serious cardiovascular events (including serious arterial and venous thromboembolic events, myocardial infarction, stroke, congestive heart ... reduction of allogeneic RBC transfusions: A higher incidence of deep venous thrombosis was documented in patients receiving PROCRIT who were not ...
... and for serious cardiovascular events (including serious arterial and venous thromboembolic events, myocardial infarction, stroke, congestive heart ... reduction of allogeneic RBC transfusions: A higher incidence of deep venous thrombosis was documented in patients receiving PROCRIT who were not ...
... Cardica conducted the 220-patient pivotal, prospective, randomized trial at 12 sites in the United States and Europe. In the trial, two venous bypass grafts were randomly selected in each patient to be connected to the aorta. The PAS-Port system was used for one graft and the conventional ...
... unnecessary fluid administration is associated with increased morbidity and mortality. Traditional invasive measurements such as central venous pressure are not reliable to predict whether a patient will benefit from fluid administration, and newer more reliable methods to predict fluid ...
... from this study is also expected to support Cardium and TRC advancing into other important product opportunities including pressure ulcers, venous stasis ulcers, bone injury repair and potentially other advanced therapeutic applications." About Cardium Cardium Therapeutics, Inc. ...
... comprehensive unit-based patient safety program across the 10 states to help prevent infections related to the use of central line catheters. Central venous catheters or central line catheters are tubes placed into a large vein in a patient's neck, chest or groin to administer medication or fluids or to ...
... devices for the minimally invasive treatment of venous reflux disease , announced today that the ... superior" to endovenous laser (EVL) for treating venous reflux, the underlying cause of symptomatic ... the great saphenous vein, the most common site of venous reflux in the leg. The RECOVERY trial was a ...
NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative Technology
... devices for the minimally invasive treatment of venous reflux disease , today announced that the UK NHS ... suffering with symptomatic varicose veins and venous reflux, and has been demonstrated in numerous ... procedure is the preferred technique to treat venous reflux because it requires no special ...CRESTOR(R) Reduced Risk of Blood Clots in the Veins
... calcium) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p =0.007) compared ... in the New England Journal of Medicine. venous thromboembolism, a serious and sometimes fatal ... is created if the clot travels through the venous system. Blood clots lodging in the lungs are ...... trial investigating the efficacy of HP802-247 in venous leg ulcers. HP802-247 is a topical spray ... to placebo plus standard care, in healing venous leg ulcers over a 12-week treatment period. ... involving subjects 18 years of age and older with venous leg ulcers of at least 6 week's, but not more ...
... the focus of a case series on eleven non-healing venous leg ulcers. These wounds had previously failed ... Leptospermum Honey (MEDIHONEY) in Recalcitrant venous Leg Wounds: A Preliminary Case Series" was ... use of MEDIHONEY - particularly in non-healing venous leg ulcers - continues to grow. This case series ...
... adequate blood flow, are known collectively as venous thromboembolism. "Venous thromboembolism ... was the combined occurrence of clinically overt venous or arterial thromboembolic events (i.e., ... the lower and upper limbs, visceral and cerebral venous thrombosis, pulmonary embolism, acute myocardial ...
Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs
... of Radiology in St. Louis, Mo. ATTRACT (Acute venous Thrombosis: Thrombus Removal With ... is chair of the DVT Research Committee of SIR's venous Forum and vice chair of the venous Disease Coalition. The Society of ...... collagen product, CellerateRx(R), on diabetic venous ulcers. "According to data released by the ... President of Wound Care Innovations. venous stasis ulcers of the lower extremity is a common ... healthcare system. It has been estimated that venous ulcers cause the loss of approximately 2 million ...
... and controlled clinical trial, looked at venous leg ulcers that had been proven to be non-healing ... paper "Bacteriological Changes in Sloughy venous Leg Ulcers Treated with Manuka Honey or Hydrogel: ... in Ireland. They concluded that for sloughy venous ulcers, "the efficacy of honey in eliminating ...
Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
... Quick, Effective Analgesia for Peripheral venous Access Procedures in Children Three to 18 ... to date on local anesthetic use for peripheral venous access procedures in children. "Increased use ... has long been urged to reduce peripheral venous access pain in children, but use of those ...... better outcomes for AF, venous thromboembolism patients INDIANAPOLIS, March 19 ... medication with chronic atrial fibrillation and venous thromboembolism. "The decision to expand ... Patients prefer fingerstick testing over painful venous draws, according to a 2002 study measuring the ...
Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective
... Distinguished Physicians' Panel at American venous Forum Presents Clinical Trial Results ... devices for the minimally invasive treatment of venous reflux disease, today presented positive clinical ... at the 20th annual meeting of the American venous Forum in Charleston, South Carolina. An ...... The current healthcare and economic burden of venous thromboembolism (VTE) in U.S. hospitals is ... to improve quality and reduce costs. About venous Thromboembolism (VTE) venous thromboembolism is a general term used to ...
... devices for the minimally invasive treatment of venous reflux disease, announced that interim results ... clearly emerging as the preferred treatment for venous reflux, in part because of reduced patient ... is the best choice for the treatment of venous reflux disease for the millions of varicose vein ...
... placebo one to three minutes prior to undergoing venous access procedures (IV insertions or blood draws). ... age. Its onset of action is one to three minutes. venous access procedures are among the most common ... pre- surgery procedures. "Pain associated with venous access procedures is a common and ...
The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
... to injectable enoxaparin in reducing the risk of venous thromboembolism (VTE) after total hip replacement ... outcome of major venous thromboembolism and venous thromboembolism-related mortality was ... 1. Lancet ref 2. Lotke PA, Lonner JH. Deep venous thrombosis prophylaxis: better living through ...... system to reduce pain associated with peripheral venous access procedures in adults. Zingo, a ... 16, 2007 to reduce the pain associated with venous access procedures, such as IV insertions or ... indication for children in the coming weeks." venous access procedures, such as IV insertions and ...
... 4568) as a potential treatment for the prevention of both arterial and venous thromboembolism; a Phase III trial is underway among patients with AF. ... as a potential new treatment for the prevention of both arterial and venous thromboembolism. Notably, Daiichi Sankyo has more than 25 years ...
Value of Genetic Testing for Preventing Blood Clots Unproven, According to New AHRQ Study
... report, titled Outcomes of Genetic Testing in Adults with a History of venous Thromboembolism , is the fifth evidence report requested for EGAPP. ... information on deep-vein thrombosis, see Preventing Hospital-Acquired venous Thromboembolism: A Guide for Effective Quality Improvement , and Your ...... versus combined placebo and standard care in patients with chronic venous ulcers. The results provided proof-of concept and dose-ranging ... wound healing following laser ablation, burn wounds, surgical wounds, venous ulcers, and diabetic ulcers. About Glycotex, Inc. Glycotex, ...
... therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients ... suggesting that oral, not transdermal estrogen may increase the risk of venous thromboembolism in postmenopausal women." Transdermal estrogen ...
Early Switch from IV to Oral Meds Is Effective for Children with Acute Bone Infection
... The traditional treatment has been to supply antibiotics through a central venous catheter over a four- to six-week period after the child returns home from ... the prolonged IV therapy had complications related to the central venous catheter." Zaoutis's study found wide variability in hospital ...... Perisurgery: PROCRIT (Epoetin alfa) increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. Consider deep venous thrombosis prophylaxis. Contraindications PROCRIT ...
Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
... both in the progression of solid tumors and the increased incidence of venous thromboembolic events observed in many malignancies. Up-regulation of ... a dual effect of inhibiting tumor growth and decreasing the incidence of venous thromboembolic events in patients with cancer. We're diligently working to ...... -- The most common adverse events were related to central venous access, such as catheterization and catheter removal, central line ... or minimally treated patients, infusion site reactions, and central venous access device (CVAD) line-associated infections. Kogenate FS is ...
Derma Sciences' MEDIHONEY(TM) Proven to Speed Healing in Stalled Leg Ulcers
... clinical trial to significantly improve the healing rates of stalled venous leg ulcers. Prior to this study, no other advanced wound care dressing, ... trial, a 108-patient randomized and controlled clinical trial, looked at venous leg ulcers that had been proven to be non-healing under standard treatment ...... however, because of the risks associated with chronic indwelling central venous catheters, including serious blood stream infections, continuous ... infusions of Remodulin are delivered using an indwelling central venous catheter. This route is associated with the risk of blood stream ...
... radiology departments. Abstract 4: "An Endovascular Approach to Deep venous Thrombosis Utilizing Isolated Thrombolysis and Adjunctive Measures," can ... subacute on chronic and 90.9 percent with chronic onset of symptoms, with venous patency achieved in all cases. No adverse events were reported in the ...
ORTHO EVRA(R) Prescribing Information Updated
... includes two new additional estimates of relative risk (odds ratios) for venous thromboembolic events (VTE) of 1.1 (indicating no increase in risk) and ... estrogen exposure may increase the risk of adverse events, including venous thromboembolism. (See CLINICAL PHARMACOLOGY, Transdermal versus Oral ...... and for serious cardiovascular events (including serious arterial and venous thromboembolic events, myocardial infarction, stroke, congestive heart ... reduction of allogeneic RBC transfusions: A higher incidence of deep venous thrombosis was documented in patients receiving PROCRIT who were not ...
... and for serious cardiovascular events (including serious arterial and venous thromboembolic events, myocardial infarction, stroke, congestive heart ... reduction of allogeneic RBC transfusions: A higher incidence of deep venous thrombosis was documented in patients receiving PROCRIT who were not ...
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
... lead product candidate, alfimeprase, for the treatment of central venous catheter occlusion (CO). This open-label, single-arm trial will evaluate ... of blood samples for laboratory testing, are often facilitated via central venous catheters. Approximately five million catheters are placed in patients in ...... Cardica conducted the 220-patient pivotal, prospective, randomized trial at 12 sites in the United States and Europe. In the trial, two venous bypass grafts were randomly selected in each patient to be connected to the aorta. The PAS-Port system was used for one graft and the conventional ...
... unnecessary fluid administration is associated with increased morbidity and mortality. Traditional invasive measurements such as central venous pressure are not reliable to predict whether a patient will benefit from fluid administration, and newer more reliable methods to predict fluid ...
TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics
... P450 2C9 genotyping test (RUO) is now available while planned menu expansion includes an extended warfarin panel with the proprietary 4F2 marker, a venous thrombosis panel (Factor II, Factor V Leiden and MTHFR) and a RESPLEX(R) respiratory pathogen assay marketed in collaboration with Qiagen that is ...... from this study is also expected to support Cardium and TRC advancing into other important product opportunities including pressure ulcers, venous stasis ulcers, bone injury repair and potentially other advanced therapeutic applications." About Cardium Cardium Therapeutics, Inc. ...
Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R)
... in Dallas, Jason R. Hanft, DPM, Director of Medical Education at Baptist Health South Florida, revealed details of a recently concluded 11-patient venous leg ulcer (VLU) case series involving the use of Derma Sciences' MEDIHONEY(R). Dr. Hanft's presentation was part of the general agenda of the ...Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density
... endometrial biopsy (arzoxifene 0, placebo 2) or in endometrial thickness, as assessed by transvaginal ultrasound. There were no deaths or venous thromboembolic events. "We are pleased with the outcomes of this study," said Adrien Sipos, M.D., Ph.D., medical director for Eli ...... comprehensive unit-based patient safety program across the 10 states to help prevent infections related to the use of central line catheters. Central venous catheters or central line catheters are tubes placed into a large vein in a patient's neck, chest or groin to administer medication or fluids or to ...
Other ContentscollapsedcollapsedcollapsedcolostomycolorectalcolorectalcolorectalcolorectalcolorectalcolorectalcolostrumcolostrumcolposcopycomedocompartmentcompartmentcompartmentcompartmentcompartmentcompartmentcomedonesOther TagsgoingoingoinlotlotlotlotlotlotthreatenthreatenfeetmammalmammalmammalmethmethmethmethmethmethhithithithithitvivovivovivovivoOther Tagsascertain 2ascertain 3ascertain 4ascertain 5point 2point 3point 4point 5point 6point 7point 8point 9point 10urine 2urine 3urine 4urine 5urine 6urine 7urine 8urine 9urine 10analgesic 2consensus 2
(Date:11/23/2009)...new study by University of Alabama at Birmingham (...and co-existing medical conditions (co-morbidity) ...ng African-Americans compared to Caucasians who al...e Nov. 23 in Cancer , a journal of the American C...ough BMI and co-morbidity are independent predicto...
(Date:11/23/2009)...d toads have existed for 360 million years and sur... fungus is threatening to make many of them extinc...f Microbiology Today . , The fungus, Batracho...ciated with waves of amphibian extinctions in Cent...0,s. Bd infects over 350 amphibian species by pene...
(Date:11/23/2009)...led how environmental irritants such as air pollut...research published today in the American Journal ...thors of the study, from Imperial College London a...ction inside the lungs that can trigger coughing w... the air. They suggest that their findings may ult...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Research reveals exactly how coughing is triggered by environmental irritants 2NanoString Technologies announces research collaboration with the Broad Institute 10781 1NanoString Technologies announces research collaboration with the Broad Institute 10781 2New Heart Attack Treatment Guidelines Stress Coordination 61607 1New Heart Attack Treatment Guidelines Stress Coordination 61607 2New Heart Attack Treatment Guidelines Stress Coordination 61607 3Scientific Link to Autism Identified 61602 1Scientific Link to Autism Identified 61602 2Scientific Link to Autism Identified 61602 3(Date:11/24/2009)...elease is available in German . , Internati...n with cancer is very good as far as survival is c...of life, pain, and long-term consequences of the d...udies. This is the conclusion of the Institute for...its final report published on 16 October 2009. , ...
(Date:11/24/2009)...bility reduced in those with undesirable blood lev... (HealthDay News) -- Abnormal cholesterol levels c...e, a new study has found. , U.S. researchers an...Heart, Lung, and Blood Institute,s Framingham Hear... had coronary heart disease at the start of the st...
(Date:11/24/2009)... New York personal injury attorney...the number of a personal injury attorney after a h...local Long Island backyard. , ...w York personal injury attorney David Perecman po...ryone should have the number of a personal injury ...
(Date:11/24/2009)... Mercy Health System will be offer...ry hosted by Robert Epstein, MD, board certified o...ter today at www.MercyWebinars.com , ...ealth System will present a live webinar on LASIK ...rough an office or home computer and is free to an...
(Date:11/24/2009)...OMERSET,N.J.,Nov.24/PRNewswire-FirstCall/--TeamSta...eandadministrativestaffingservices,todayannouncedt...ockfromTheNasdaqGlobalMarkettoTheNasdaqCapitalMark...iveattheopeningofbusinessonWednesday,November25,20...derthesymbol"TSTF."TheNasdaqCapitalMarketisacontin...
Breaking Medicine News(10 mins):Health News:In Germany, children with cancer have a high probability of survival 2Health News:In Germany, children with cancer have a high probability of survival 3Health News:Cholesterol Plays Role in Heart Failure Risk 2Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 2Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 3Health News:Free LASIK Surgery Webinar 2Health News:Free LASIK Surgery Webinar 3Health News:Free LASIK Surgery Webinar 4Health News:TeamStaff Announces Transfer to Nasdaq Capital Market 2Health News:TeamStaff Announces Transfer to Nasdaq Capital Market 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |